• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病:全球性问题。

Chronic obstructive pulmonary disease: a worldwide problem.

机构信息

Fundació Caubet-CIMERA Illes Balears, Recinte Hospital Joan March, Mallorca, Illes Balears, Spain.

出版信息

Med Clin North Am. 2012 Jul;96(4):671-80. doi: 10.1016/j.mcna.2012.02.005.

DOI:10.1016/j.mcna.2012.02.005
PMID:22793937
Abstract

Respiratory diseases receive little attention and funding in comparison with other major causes of global morbidity and mortality. Chronic obstructive pulmonary disease (COPD) has been a major public health problem and will remain a challenge for clinicians within the twenty-first century. Worldwide, COPD is in the spotlight because of its high prevalence, morbidity, and mortality, and creates formidable challenges for health care systems. This review summarizes the magnitude of the COPD problem at the population and individual levels.

摘要

与其他主要的全球发病率和死亡率原因相比,呼吸系统疾病得到的关注和资金都较少。慢性阻塞性肺疾病(COPD)一直是一个主要的公共卫生问题,并且在二十一世纪仍将是临床医生面临的挑战。在全球范围内,由于 COPD 的高患病率、发病率和死亡率,它成为了焦点,并且给医疗保健系统带来了巨大的挑战。这篇综述总结了在人群和个体层面上 COPD 问题的严重程度。

相似文献

1
Chronic obstructive pulmonary disease: a worldwide problem.慢性阻塞性肺疾病:全球性问题。
Med Clin North Am. 2012 Jul;96(4):671-80. doi: 10.1016/j.mcna.2012.02.005.
2
Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation.慢性阻塞性肺疾病概述:流行病学、危险因素和临床表现。
Proc Am Thorac Soc. 2011 Aug;8(4):363-7. doi: 10.1513/pats.201102-017RM.
3
Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.高收入和低收入国家慢性阻塞性肺疾病的全球负担。第一部分。阻塞性肺病负担(BOLD)倡议。
Int J Tuberc Lung Dis. 2008 Jul;12(7):703-8.
4
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.慢性阻塞性肺疾病诊断、管理和预防全球策略:GOLD执行摘要
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.
5
The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.瑞典乌普萨拉慢性阻塞性肺疾病的患病率——慢性阻塞性肺病负担(BOLD)研究:基于人群的横断面研究
Clin Respir J. 2012 Apr;6(2):120-7. doi: 10.1111/j.1752-699X.2011.00257.x. Epub 2011 Jul 6.
6
Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies.高收入和低收入国家慢性阻塞性肺疾病的全球负担。第三部分。亚太地区研究。
Int J Tuberc Lung Dis. 2008 Jul;12(7):713-7.
7
Global burden of COPD.慢性阻塞性肺疾病的全球负担。
Respirology. 2016 Jan;21(1):14-23. doi: 10.1111/resp.12660. Epub 2015 Oct 23.
8
Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution.慢性阻塞性肺疾病的流行病学:空气污染对健康的影响
Respirology. 2006 Sep;11(5):523-32. doi: 10.1111/j.1440-1843.2006.00886.x.
9
[Prevalence of chronic obstructive pulmonary disease (COPD) and other pulmonary diseases among participants of the program of early detection and prevention of COPD].[慢性阻塞性肺疾病(COPD)早期检测与预防项目参与者中慢性阻塞性肺疾病及其他肺部疾病的患病率]
Przegl Lek. 2004;61(10):1052-6.
10
COPD management. Part II. Relevance for resource-poor settings.慢性阻塞性肺疾病的管理。第二部分。对资源匮乏地区的意义。
Int J Tuberc Lung Dis. 2008 Jun;12(6):595-600.

引用本文的文献

1
Prevalence and risk factors for COPD in subjects with preserved ratio impaired spirometry.在肺功能正常但比预计值差的患者中 COPD 的流行率和危险因素。
BMJ Open Respir Res. 2022 Jul;9(1). doi: 10.1136/bmjresp-2022-001298.
2
Prediction of cardiovascular risk in patients with chronic obstructive pulmonary disease: a study of the National Health and Nutrition Examination Survey database.慢性阻塞性肺疾病患者心血管风险预测:国家健康和营养调查数据库研究。
BMC Cardiovasc Disord. 2021 Sep 1;21(1):417. doi: 10.1186/s12872-021-02225-w.
3
Effect of Liuzijue Qigong on patients with chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis.
六字诀气功对慢性阻塞性肺疾病患者的影响:系统评价与Meta分析方案
Medicine (Baltimore). 2018 Oct;97(40):e12659. doi: 10.1097/MD.0000000000012659.
4
Potential targets for next generation antimicrobial glycoconjugate vaccines.新一代抗菌糖缀合物疫苗的潜在靶标。
FEMS Microbiol Rev. 2018 May 1;42(3):388-423. doi: 10.1093/femsre/fuy011.
5
Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease.美国慢性阻塞性肺疾病患者对正确吸入器技术的信心及其与治疗依从性和健康状况的关联。
Patient Prefer Adherence. 2017 Jul 12;11:1205-1212. doi: 10.2147/PPA.S140139. eCollection 2017.
6
Genetic Polymorphism of Angiotensin-Converting Enzyme and Chronic Obstructive Pulmonary Disease Risk: An Updated Meta-Analysis.血管紧张素转换酶基因多态性与慢性阻塞性肺疾病风险:一项更新的荟萃分析。
Biomed Res Int. 2016;2016:7636123. doi: 10.1155/2016/7636123. Epub 2016 Oct 18.
7
Fine particulate matter in acute exacerbation of COPD.慢性阻塞性肺疾病急性加重期的细颗粒物
Front Physiol. 2015 Oct 23;6:294. doi: 10.3389/fphys.2015.00294. eCollection 2015.
8
Incidence of chronic obstructive pulmonary disease based on three spirometric diagnostic criteria in Sao Paulo, Brazil: a nine-year follow-up since the PLATINO prevalence study.基于三种肺功能诊断标准的巴西圣保罗慢性阻塞性肺疾病发病率:PLATINO患病率研究后的九年随访
Sao Paulo Med J. 2015 May-Jun;133(3):245-51. doi: 10.1590/1516-3180.2015.9620902. Epub 2015 Jun 1.
9
Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.在中国以中重度慢性阻塞性肺疾病为主的患者中,每日一次格隆溴铵的疗效和安全性:GLOW7研究
Int J Chron Obstruct Pulmon Dis. 2015 Jan 5;10:57-68. doi: 10.2147/COPD.S72650. eCollection 2015.
10
The Saudi Guidelines for the Diagnosis and Management of COPD.沙特阿拉伯慢性阻塞性肺疾病诊断和管理指南。
Ann Thorac Med. 2014 Apr;9(2):55-76. doi: 10.4103/1817-1737.128843.